Contract Pharmaceutical Manufacturing Industry
Description
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and so on, which required for pharmaceutical manufacturing. The main type of contract pharmaceutical manufacturing is API and FDF.
The contract pharmaceutical manufacturing industry is not very concentrated the revenue of top eighteenth manufacturers account about 22% of global revenue.
In the world wide, the major manufactures mainly distribute in North America and Europe. The transnational companies, like Catalent and DPx, are the leading manufactures in the World.
North America and Europe is the industry’s leading region. In 2015, the revenue of contract pharmaceutical manufacturing is about 19 billion USD in North America; its proportion of total global revenue exceeds 32%. In 2015, the revenue is about 14 billion USD in Europe. Japan and India have witnessed a major chunk developing of the contract pharmaceutical manufacturing in the Asia region. Especially India, its revenue is 8 billion USD in 2015.
Global Contract Pharmaceutical Manufacturing market size will increase to 108800 Million US$ by 2025, from 68700 Million US$ in 2018, at a CAGR of 5.9% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Contract Pharmaceutical Manufacturing.
This report researches the worldwide Contract Pharmaceutical Manufacturing market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Contract Pharmaceutical Manufacturing breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.
The following manufacturers are covered in this report:
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3754677-global-contract-pharmaceutical-manufacturing-market-insights-forecast-to-2025
Contract Pharmaceutical Manufacturing Breakdown Data by Type
API
FDF
Contract Pharmaceutical Manufacturing Breakdown Data by Application
Specialty/Midsize
Generics
Big Pharma
Other
Contract Pharmaceutical Manufacturing Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Leave a Query @ https://www.wiseguyreports.com/enquiry/3754677-global-contract-pharmaceutical-manufacturing-market-insights-forecast-to-2025
Table of Contents
Global Contract Pharmaceutical Manufacturing Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
1.1 Contract Pharmaceutical Manufacturing Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type
1.4.2 API
1.4.3 FDF
1.5 Market by Application
1.5.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application
1.5.2 Specialty/Midsize
1.5.3 Generics
1.5.4 Big Pharma
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Contract Pharmaceutical Manufacturing Production
2.1.1 Global Contract Pharmaceutical Manufacturing Revenue 2014-2025
2.1.2 Global Contract Pharmaceutical Manufacturing Production 2014-2025
2.1.3 Global Contract Pharmaceutical Manufacturing Capacity 2014-2025
2.1.4 Global Contract Pharmaceutical Manufacturing Marketing Pricing and Trends
2.2 Contract Pharmaceutical Manufacturing Growth Rate (CAGR) 2019-2025
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Contract Pharmaceutical Manufacturing Manufacturers
2.4 Market Drivers, Trends and Issues
2.5 Macroscopic Indicator
2.5.1 GDP for Major Regions
2.5.2 Price of Raw Materials in Dollars: Evolution
…
8 Manufacturers Profiles
8.1 Catalent
8.1.1 Catalent Company Details
8.1.2 Company Description
8.1.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.1.4 Contract Pharmaceutical Manufacturing Product Description
8.1.5 SWOT Analysis
8.2 DPx
8.2.1 DPx Company Details
8.2.2 Company Description
8.2.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.2.4 Contract Pharmaceutical Manufacturing Product Description
8.2.5 SWOT Analysis
8.3 Lonza
8.3.1 Lonza Company Details
8.3.2 Company Description
8.3.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.3.4 Contract Pharmaceutical Manufacturing Product Description
8.3.5 SWOT Analysis
8.4 Piramal Healthcare
8.4.1 Piramal Healthcare Company Details
8.4.2 Company Description
8.4.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.4.4 Contract Pharmaceutical Manufacturing Product Description
8.4.5 SWOT Analysis
8.5 Aenova
8.5.1 Aenova Company Details
8.5.2 Company Description
8.5.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.5.4 Contract Pharmaceutical Manufacturing Product Description
8.5.5 SWOT Analysis
8.6 Jubilant
8.6.1 Jubilant Company Details
8.6.2 Company Description
8.6.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.6.4 Contract Pharmaceutical Manufacturing Product Description
8.6.5 SWOT Analysis
8.7 Famar
8.7.1 Famar Company Details
8.7.2 Company Description
8.7.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.7.4 Contract Pharmaceutical Manufacturing Product Description
8.7.5 SWOT Analysis
8.8 Boehringer Ingelheim
8.8.1 Boehringer Ingelheim Company Details
8.8.2 Company Description
8.8.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.8.4 Contract Pharmaceutical Manufacturing Product Description
8.8.5 SWOT Analysis
8.9 Fareva Holding
8.9.1 Fareva Holding Company Details
8.9.2 Company Description
8.9.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.9.4 Contract Pharmaceutical Manufacturing Product Description
8.9.5 SWOT Analysis
8.10 AbbVie
8.10.1 AbbVie Company Details
8.10.2 Company Description
8.10.3 Capacity, Production and Value of Contract Pharmaceutical Manufacturing
8.10.4 Contract Pharmaceutical Manufacturing Product Description
8.10.5 SWOT Analysis
8.11 Nipro Corp
8.12 Vetter
8.13 Sopharma
8.14 DPT Laboratories
8.15 Recipharm
8.16 NextPharma
8.17 Dishman
8.18 Aesica
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3754677
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/3754677-global-contract-pharmaceutical-manufacturing-market-insights-forecast-to-2025